Developing real-world prognostic models for patients with advanced hepatocellular carcinoma: CRAFITY, mALF and beyond

被引：2
|
作者：
Huo, Teh-Ia [1 ,3 ]
Liao, Jia-, I [2 ,4 ]
Ho, Shu-Yein [4 ,5 ]
机构：
[1] Taipei Vet Gen Hosp, Dept Med Res, 201, Sec 2, Shipai Rd, Taipei 11217, Taiwan
[2] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Inst Pharmacol, Taipei, Taiwan
[4] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan
[5] Min Sheng Gen Hosp, Div Gastroenterol & Hepatol, Taoyuan, Taiwan
来源：
HEPATOLOGY INTERNATIONAL | 2023年 / 17卷 / 02期
关键词：
SCORE;
D O I：
10.1007/s12072-022-10467-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：512 / 513
页数：2
相关论文
共 50 条
  • [31] Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
    Kuo, Yuan-Hung
    Lu, Sheng-Nan
    Chen, Yen-Yang
    Kee, Kwong-Ming
    Yen, Yi-Hao
    Hung, Chao-Hung
    Hu, Tsung-Hui
    Chen, Chien-Hung
    Wang, Jing-Houng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] Real-World Use of Immunotherapy for Hepatocellular Carcinoma
    Sara, Amir
    Ruff, Samantha M.
    Noonan, Anne M.
    Pawlik, Timothy M.
    PRAGMATIC AND OBSERVATIONAL RESEARCH, 2023, 14 : 63 - 74
  • [33] A real-world study of Chinese hepatocellular carcinoma patients treated with TACE
    Hu, H-F
    Sang, Y-F
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (09) : 3091 - 3099
  • [34] Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis
    Singal, Amit G.
    Nagar, Saurabh P.
    Hitchens, Abby
    Davis, Keith L.
    Iyer, Shrividya
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (03)
  • [35] REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA IN THE UNITED STATES
    Dayyani, Farshid
    Mhatre, Shivani
    Ferro, Ana
    Lawrance, Marcus
    Gaillard, Vincent
    Morse, Michael
    HEPATOLOGY, 2020, 72 : 650A - 651A
  • [36] Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma
    Procopio, Giuseppe
    Bamias, Aristotelis
    Schmidinger, Manuela
    Hawkins, Robert
    Rodriguez Sanchez, Angel
    Vazquez Estevez, Sergio
    Srihari, Narayanan
    Kalofonos, Haralabos
    Bono, Petri
    Babanrao, Chaitali
    Hirschberg, Yulia
    Dezzani, Luca
    Ahmad, Qasim
    Suarez Rodriguez, Cristina
    Jonasch, Eric
    CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : E526 - E533
  • [37] LENVATINIB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD PRACTICE - MULTICENTER ANALYSIS OF PROGNOSTIC FACTORS
    Hiraoka, Atsushi
    Kumada, Takashi
    Atsukawa, Masanori
    Hirooka, Masashi
    Ishikawa, Toru
    Kunihiko, Tsuji
    Takaguchi, Koichi
    Kariyama, Kazuya
    Itobayashi, Ei
    Tajiri, Kazuto
    Shimada, Noritomo
    Shibata, Hiroshi
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi, Sr.
    Nagano, Takuya
    Itokawa, Norio
    Hayama, Korenobu
    Imai, Michitaka
    Joko, Kouji
    Koizumi, Yohei
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    HEPATOLOGY, 2019, 70 : 217A - 218A
  • [38] Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis
    Hiroaki Kanzaki
    Sadahisa Ogasawara
    Tomomi Okubo
    Norio Itokawa
    Ryohei Yoshino
    Kentaro Fujimoto
    Tadayoshi Kogure
    Sae Yumita
    Takamasa Ishino
    Keita Ogawa
    Terunao Iwanaga
    Miyuki Nakagawa
    Kisako Fujiwara
    Ryuta Kojima
    Keisuke Koroki
    Masanori Inoue
    Kazufumi Kobayashi
    Naoya Kanogawa
    Soichiro Kiyono
    Masato Nakamura
    Takayuki Kondo
    Ryo Nakagawa
    Shingo Nakamoto
    Ryosuke Muroyama
    Ei Itobayashi
    Masanori Atsukawa
    Jun Kato
    Naoya Kato
    Drugs - Real World Outcomes, 2023, 10 : 513 - 520
  • [39] Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis
    Kanzaki, Hiroaki
    Ogasawara, Sadahisa
    Okubo, Tomomi
    Itokawa, Norio
    Yoshino, Ryohei
    Fujimoto, Kentaro
    Kogure, Tadayoshi
    Yumita, Sae
    Ishino, Takamasa
    Ogawa, Keita
    Iwanaga, Terunao
    Nakagawa, Miyuki
    Fujiwara, Kisako
    Kojima, Ryuta
    Koroki, Keisuke
    Inoue, Masanori
    Kobayashi, Kazufumi
    Kanogawa, Naoya
    Kiyono, Soichiro
    Nakamura, Masato
    Kondo, Takayuki
    Nakagawa, Ryo
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Itobayashi, Ei
    Atsukawa, Masanori
    Kato, Jun
    Kato, Naoya
    DRUGS-REAL WORLD OUTCOMES, 2023, 10 (04) : 513 - 520
  • [40] Real-World, Observational, Retrospective Study to Evaluate the Effectiveness and Safety of Treatment with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
    Csipak, Angelica Richart
    da Fonseca, Leonardo G.
    Lopez, Rossana Veronica Mendoza
    Estevez-Diz, Maria Del Pilar
    CURRENT ONCOLOGY, 2024, 31 (11) : 6778 - 6790
12345